FDA panics to give Roche breakthrough designation for THEIR Alzheimer's biomarker blood test, because horror of horrors, they reluctantly had to approve a non-Big Pharma company's blood test last May.

Roche article link:
https://www.fiercebiotech.com/medtech/roches-...ough-label

First blood test approved last May, by Fujirebio
https://www.fiercebiotech.com/medtech/fda-cle...rs-disease

FDA's mission: make sure Big Pharma always has a competitive advantage. ("Hey fellas, we had to finally approve that other company's test, let's grant Breakthrough Designation to Roche even though you're not supposed to grant it if there is already a product approved that does the same thing. My Swiss bank account level needs to be higher....." )